United States · FDA National Drug Code directory
Olanzapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-263_4dfd2813-fd81-7a75-9002-81b558aef7bf
- Product NDC
- 55111-263
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Olanzapine
- Labeler
- Dr.Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20111024
- Source listing expiry
- 20271231
Source-listed ingredients
- OLANZAPINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (55111-263-79) · 55111-263-79
- 3 BLISTER PACK in 1 CARTON (55111-263-81) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 55111-263-81
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →